<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
Sabratek Corporation
(Name of Issuer)
Common Stock
(Title of Class of Securities)
78571 U 10 8
(Cusip Number)
Robert C. Gienko
Suite 110, 3315 West Algonquin Road., Rolling Meadows, Illinois 60008
Tel: (847) 259-7373
(Name, Address and Telephone Number of Person Authorized to
Receive Notes and Communications)
June 29, 1999
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject o this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b) (3) or (4), check the following box | |.
Check the following box if a fee is being paid with the statement | |. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described. In Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13a-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE> 2
SCHEDULE 13D
- ------------------------------ -------------------------------------
CUSIP NO. 78571 U 10 8 Page 2 of 4 Pages
- ------------------------------ -------------------------------------
- --------------------------------------------------------------------------------
1 NAME OR REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Robert C. Gienko S.S.N.: ###-##-####
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) | |
(b) | |
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e)
|__|
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
The United States of America
- --------------------------------------------------------------------------------
7 Sole Voting Power 1,003,454
NUMBER OF -------------------------------------------------------
SHARES 8 Shared Voting Power 0
BENEFICIALLY -------------------------------------------------------
OWNED BY 9 Sole Dispositive Power 1,003,454
EACH -------------------------------------------------------
REPORTING 10 Shared Dispositive Power 0
PERSON
WITH
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,003,454
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
|__|
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.04%
- --------------------------------------------------------------------------------
14 TYPE OF PERSON REPORTING*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION
- --------------------------------------------------------------------------------
2
<PAGE> 3
Item 1. Security and Issuer.
This Schedule 13-D, dated July 9, 1999, filed by Robert C. Gienko,
relates to the common stock, par value of $.01 per share (the "Sabratek Common
Stock"), of Sabratek Corporation, a Delaware corporation (the "Issuer" of
"Sabratek"). The principal executive offices of the Issuer are located at 8111
North St. Louis Avenue, Skokie, Illinois 60076. All capitalized terms used
herein shall have the definitions set forth in the Schedule, except as may
otherwise be provided herein.
Item 2. Identity and Background.
This statement is being filed by Robert C. Gienko. His business address
is Suite 110, 3315 West Algonquin Road, Rolling Meadows, Illinois 60008.
During the last five years, Mr. Gienko has never been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors), nor
has he been party to a civil proceeding of a judicial or administrative body of
competent jurisdiction as a result of which Mr. Gienko was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding
any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration.
On June 29, 1999, Sabratek issued to Mr. Gienko a total of 965,454
shares of Sabratek Common Stock in connection with the acquisition of Strategic
Reimbursement Services, Inc. ("SRS"). Prior to Sabratek's acquisition of SRS,
Mr. Gienko was a 59% shareholder of SRS. At the time of the Issuer's acquisition
of SRS, Mr. Gienko owned 38,000 shares of Sabratek Common Stock which he
acquired with his personal funds.
Item 4. Purpose of Transaction.
NONE
Item 5. Interest in Securities of the Issuer.
As of June 29, 1999, Mr. Gienko is deemed to beneficially own 1,003,454
shares of Sabratek Common Stock (approximately 8.04% of the Sabratek Common
Stock outstanding). The percentage of Sabratek Common Stock beneficially owned
by Mr. Gienko is calculated based upon the total number of shares of Sabratek
Common Stock outstanding as of the close of business on June 29, 1999.
Set forth below is information with respect to all of Mr. Gienko's
transactions in the Sabratek Common Stock within the 60 day period preceding the
date of this filing.
3
<PAGE> 4
Date Transaction Number of Shares Price Per Share
- ---- ----------- ---------------- ---------------
6/29/99 Sale on Nasdaq National Market 1,000 $21-3/8
6/29/99 Sale on Nasdaq National Market 2,000 $21-1/4
6/29/99 Sale on Nasdaq National Market 1,500 $21-13/16
6/29/99 Sale on Nasdaq National Market 2,000 $21-1/2
6/29/99 Sale on Nasdaq National Market 500 $21-7/8
6/29/99 Acquisition (see Item 3) 965,454 N/A
Item 6. Contracts, Arrangements, Understandings or Relationship with Respect
to Securities of the Issuer.
NONE
Item 7. Material to be Filed as Exhibits.
NONE
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: July 9, 1999
By: /s/ Robert C. Gienko
------------------------------
Name: Robert C. Gienko
4
